Andreas Fouras
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Andreas Fouras
Founder, Chief Executive, Managing Director, Chief Technology Officer / 4DMedical
Dr Andreas Fouras started his career in academic research studying experimental fluid dynamics in the Department of Mechanical and Aerospace Engineering at Monash University in Melbourne. His early research in wind tunnel quantification placed him as a young leader in the area of imaging (within fluid dynamics) developing a number of new approaches to the imaging of gas and liquid flow. His research has been documented in over 100 peer reviewed publications, and over 40 patents and patent applications.
Dr Fouras was a Professor and director of the Laboratory for Dynamic Imaging. He founded 4DMedical in December 2012 and is its chief executive, managing director and chief technology officer.
Dr Fouras received awards from a range of research bodies including the National Health and Medical Research Council, the American Asthma Foundation, and the 2013 Australian Davos Connection Australian Leadership Award.
Dr Fouras was a Professor and director of the Laboratory for Dynamic Imaging. He founded 4DMedical in December 2012 and is its chief executive, managing director and chief technology officer.
Dr Fouras received awards from a range of research bodies including the National Health and Medical Research Council, the American Asthma Foundation, and the 2013 Australian Davos Connection Australian Leadership Award.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 142nd | 4DMedical | 68% | |
| 860th | Ironbark Capital | -9% | 3% |
| 1124th | Bill Identity | -27% | |
| 1594th | Actinogen Medical | -59% | -9% |
| 1644th | Chimeric Therapeutics | -62% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 744th |  | 4DMedical | $13.9m |
| 864th | | Chimeric Therapeutics | $4.9m |
| 865th | | Ironbark Capital | $4.9m |
| 867th | | Actinogen Medical | $4.8m |
| 868th | | Bill Identity | $4.7m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Founder, Chief Executive, Managing Director, Chief Technology Officer, 4DMedical | 03 Nov 2020 |
